{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:17Z","timestamp":1790964677767,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31400148"],"award-info":[{"award-number":["31400148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["14YF1407600"],"award-info":[{"award-number":["14YF1407600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.antiviral.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T16:39:01Z","timestamp":1463503141000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus"],"prefix":"10.1016","volume":"132","author":[{"given":"Rui","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Altmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-7827","authenticated-orcid":false,"given":"Gang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.05.010_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.1890190306","article-title":"Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden","volume":"19","author":"Akerlind","year":"1986","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"American Academy of Pediatrics Committee on Infectious, D., American Academy of Pediatrics Bronchiolitis Guidelines, C","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2016.05.010_bib3","doi-asserted-by":"crossref","first-page":"e620","DOI":"10.1542\/peds.2014-1666","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","author":"American Academy of Pediatrics Committee on Infectious, D., American Academy of Pediatrics Bronchiolitis Guidelines, C.","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.antiviral.2016.05.010_bib4","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/151.4.626","article-title":"Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies","volume":"151","author":"Anderson","year":"1985","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.05.010_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/10641969809053247","article-title":"The cellular mechanism of action of cardiotonic steroids: a new hypothesis","volume":"20","author":"Blaustein","year":"1998","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.antiviral.2016.05.010_bib6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathogenic agent from chimpanzees with coryza","volume":"92","author":"Blount","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2016.05.010_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.antiviral.2016.05.010_bib8","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1128\/AAC.00211-07","article-title":"RSV604, a novel inhibitor of respiratory syncytial virus replication","volume":"51","author":"Chapman","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.05.010_bib9","first-page":"235","article-title":"Respiratory syncytial virus disease: prevention and treatment","volume":"372","author":"Chu","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/oxfordjournals.aje.a120586","article-title":"An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test","volume":"83","author":"Coates","year":"1966","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3181\/00379727-112-28221","article-title":"Antigenic differences between two strains of respiratory syncytial virus","volume":"112","author":"Coates","year":"1963","journal-title":"Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2016.05.010_bib12","series-title":"Fields Virology","first-page":"1601","article-title":"Respiratory syncytial virus and metapneumoviruses","author":"Collins","year":"2007"},{"key":"10.1016\/j.antiviral.2016.05.010_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.05.010_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.7754\/Clin.Lab.2015.141242","article-title":"Tetrandrine inhibits the intracellular calcium ion level and upregulates the expression of Brg1 and AHNAK in Hep-2 cells","volume":"61","author":"Cui","year":"2015","journal-title":"Clin. Lab."},{"key":"10.1016\/j.antiviral.2016.05.010_bib15","doi-asserted-by":"crossref","first-page":"e1004995","DOI":"10.1371\/journal.ppat.1004995","article-title":"Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2\u2019-Fluoro-4\u2019-Chloromethyl-Cytidine Triphosphate","volume":"11","author":"Deval","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.05.010_bib16","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMoa1413275","article-title":"Activity of oral ALS-008176 in a respiratory syncytial virus challenge study","volume":"373","author":"DeVincenzo","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.05.010_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1401184","article-title":"Oral GS-5806 activity in a respiratory syncytial virus challenge study","volume":"371","author":"DeVincenzo","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.05.010_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","article-title":"A\u00a0historical overview of natural products in drug discovery","volume":"2","author":"Dias","year":"2012","journal-title":"Metabolites"},{"key":"10.1016\/j.antiviral.2016.05.010_bib19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.05.010_bib20","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.05108-14","article-title":"Discovery of itraconazole with broad-spectrum in\u00a0vitro antienterovirus activity that targets nonstructural protein 3A","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.05.010_bib21","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0006-2952(88)90195-5","article-title":"Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles","volume":"37","author":"Goeger","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2016.05.010_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd4510","article-title":"The re-emergence of natural products for drug discovery in the genomics era","volume":"14","author":"Harvey","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2016.05.010_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/infdis\/160.2.185","article-title":"Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981\u20131987","volume":"160","author":"Hendry","year":"1989","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.05.010_bib25","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/0040-4020(68)88113-X","article-title":"The isolation and structure of cyclopiazonic acid, a toxic metabolite of Penicillium cyclopium Westling","volume":"24","author":"Holzapfel","year":"1968","journal-title":"Tetrahedron"},{"key":"10.1016\/j.antiviral.2016.05.010_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00232868","article-title":"Specific inhibitors of intracellular Ca2+ transport ATPases","volume":"141","author":"Inesi","year":"1994","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib27","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1073\/pnas.84.16.5625","article-title":"The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins","volume":"84","author":"Johnson","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.05.010_bib28","doi-asserted-by":"crossref","first-page":"15192","DOI":"10.1016\/S0021-9258(19)84809-3","article-title":"2,5-Di-(tert-butyl)-1,4-benzohydroquinone rapidly elevates cytosolic Ca2+ concentration by mobilizing the inositol 1,4,5-trisphosphate-sensitive Ca2+ pool","volume":"264","author":"Kass","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.05.010_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1586\/eri.10.140","article-title":"Respiratory syncytial virus disease: update on treatment and prevention","volume":"9","author":"Krilov","year":"2011","journal-title":"Expert Rev. Anti-Infective Ther."},{"key":"10.1016\/j.antiviral.2016.05.010_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.inf.0000121203.33560.f9","article-title":"Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab","volume":"23","author":"Meissner","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2016.05.010_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/infdis\/157.1.143","article-title":"Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981\u20131986","volume":"157","author":"Mufson","year":"1988","journal-title":"J.\u00a0Infect. Dis."},{"issue":"Pt 10","key":"10.1016\/j.antiviral.2016.05.010_bib32","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-66-10-2111","article-title":"Two distinct subtypes of human respiratory syncytial virus","volume":"66","author":"Mufson","year":"1985","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib33","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.05.010_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0895-4356(96)00137-0","article-title":"Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection","volume":"49","author":"Ohmit","year":"1996","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.jbchem.a124575","article-title":"Transport of envelope proteins of Sendai virus, HN and F0, is blocked at different steps by thapsigargin and other perturbants to intracellular Ca2+","volume":"116","author":"Ono","year":"1994","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.antiviral.2016.05.010_bib36","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/AAC.01497-15","article-title":"GS-5806 inhibits a broad range of respiratory syncytial virus clinical isolates by blocking the virus-cell fusion process","volume":"60","author":"Perron","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.05.010_bib37","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/01.RES.67.6.1494","article-title":"Ouabain increases the calcium concentration in intracellular stores involved in stimulus-response coupling in human platelets","volume":"67","author":"Roevens","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2016.05.010_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virusres.2007.06.005","article-title":"Intracellular disassembly of infectious rotavirus particles by depletion of Ca2+ sequestered in the endoplasmic reticulum at the end of virus cycle","volume":"130","author":"Ruiz","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.05.010_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2016.05.010_bib40","doi-asserted-by":"crossref","first-page":"17816","DOI":"10.1016\/S0021-9258(19)84646-X","article-title":"Cyclopiazonic acid is a specific inhibitor of the Ca2+-ATPase of sarcoplasmic reticulum","volume":"264","author":"Seidler","year":"1989","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.05.010_bib41","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JCM.31.5.1224-1231.1993","article-title":"Analysis of respiratory syncytial virus genetic variability with amplified cDNAs","volume":"31","author":"Sullender","year":"1993","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2016.05.010_bib42","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1073\/pnas.87.7.2466","article-title":"Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase","volume":"87","author":"Thastrup","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.05.010_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.virusres.2006.01.020","article-title":"Involvement of endoplasmic reticulum in hepatitis B virus replication","volume":"121","author":"Xia","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.05.010_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T06:45:12Z","timestamp":1656053112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":44,"alternative-id":["S0166354216300997"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.05.010","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclopiazonic acid, an inhibitor of calcium-dependent ATPases with antiviral activity against human respiratory syncytial virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}